- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2021
- 420 Pages
United States
From €2184EUR$2,400USD£1,873GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Book
- February 2024
- 592 Pages
Phenelzine is a monoamine oxidase inhibitor (MAOI) used to treat mental disorders such as depression, anxiety, and panic disorder. It works by increasing the levels of certain neurotransmitters in the brain, which can help improve mood and reduce symptoms of mental illness. Phenelzine is generally prescribed when other treatments, such as selective serotonin reuptake inhibitors (SSRIs), have not been effective. It is usually taken once or twice a day and can take several weeks to start working.
Phenelzine is a commonly prescribed medication for mental disorders, and is available in both generic and brand-name forms. It is available in tablet, capsule, and liquid forms, and is usually taken orally. Common side effects include drowsiness, dizziness, and dry mouth. More serious side effects can include changes in blood pressure, increased heart rate, and confusion.
The phenelzine market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, and Mylan. Show Less Read more